On June 23, 2026, the Department of Justice (DOJ) announced the results of the 2026 National Health Care Fraud Takedown. The so-called “takedowns” have become an annual event, and this year’s involved the largest number of defendants in Takedown history. For healthcare providers and organizations, the takeaway is clear: Enforcement is nationally coordinated, increasingly data-driven
On February 18, 2025, the First Circuit joined the Sixth and Eighth Circuits in adopting a “but for” causation standard in cases involving per se liability under the federal Anti-Kickback Statute (AKS) and the False Claims Act (FCA). In U.S. v. Regeneron Pharmaceuticals, the First Circuit held that for an AKS violation to automatically
On Wednesday, May 10, 2023, U.S. Rep. George Santos was charged in a 13-count federal indictment in the Eastern District of New York. Elected in 2022, Rep. Santos represents New York’s 3rd Congressional District, covering the North Shore of Long Island and parts of Queens. His short tenure has already been marked by controversy
On April 20, 2023, the Department of Justice announced criminal charges against 18 defendants in nine federal districts, alleging over $490 million in alleged theft from federally funded COVID-19 relief programs. This clearly shows that, even as the COVID-19 pandemic continues to recede into the national memory—evidenced by the recent culmination of the national emergency
On March 1, 2023, the White House announced the National Cybersecurity Strategy, a coordinated strategy to secure data with a focus on increasing cybersecurity for every company and individual within our great country. The strategy revolves around five pillars intended to build “enduring collaboration between stakeholders across our digital ecosystem” to ensure “that the underlying
As Medicare Advantage attracts more eligible beneficiaries, it is also drawing attention from False Claims Act (FCA) prosecutors. In 2022, enrollment in Medicare Advantage plans reached 28.7 million Medicare beneficiaries, or 49% of eligible beneficiaries. Recently, the United States intervened in a qui tam case against Cigna filed in the Southern District of New York and